Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830212) titled 'Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study' on Sept. 15.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Yong He
Condition:
Prostatic Neoplasms
Prostate Cancer
Intervention:
Drug: [68Ga]Ga-OncoACP3
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 2026
Target Sample Size: 50
Countries of Recruitment:
China
To know more, visit http...